News

Study attributes 60-70% of excess heart disease among low-income Americans to poverty rather than traditional risk factors

The COVID-19 epidemic has brought attention to longstanding health disparities in the United States. Heart disease, a key risk factor for severe COVID illness, is more widespread among lower-income Americans and may be a factor in the disproportionate effect of COVID-19 in low-income communities in...

UCSF Partners with State to Develop Public Health Workforce for COVID-19 Response

UC San Francisco is launching a workforce training and technical assistance program on May 6, 2020, in partnership with the California Department of Public Health, to facilitate the training of thousands of individuals across the state in public health techniques and strategies, including contact...

Vittinghoff Innovation Award Call for Entries

We are encouraging nominations for the Vittinghoff Innovation Award. The $500 award – which honors Professor Eric Vittinghoff, MPH, PhD, for his vast contributions to epidemiological research – recognizes methodologically innovative work in epidemiologic, clinical, or translational research by...

This Time Must Be Different: Disparities During the COVID-19 Pandemic

This note was first published with references in the Annals of Internal Medicine.

Katie Pollard Named 2020 ISCB Fellow

The International Society for Computational Biology (ISCB) has named Katie Pollard, PhD, a 2020 ISCB Fellow. She was selected for being a “world leader in developing statistical models and open-source bioinformatics software for biological big data, with an emphasis on genomics.” Pollard was one of...

Science during a crisis: Faculty look to clinical trials to find drugs that combat Covid-19

Much of the news coverage of the COVID-19 epidemic has pointed to the promise of the anti-malarial drug hydroxychloroquine to combat the novel coronavirus that causes COVID-19. Hydroxychloroquine is one of three drugs that researchers have flagged as possible treatments for COVID-19.

Coronavirus Survivors Hope for Immunity — The Reality Is More Complicated

This article first appeared on Bloomberg.com As the number of new Covid-19 cases each day begins to slow in parts of the U.S. and states consider rolling back social-distancing measures, a huge unknown remains: Who has become immune to the disease — and for how long?

UCSF launches dashboard to track how social determinants affect population health

This article was first published in Becker's Hospital Review.

To aid coronavirus fight, The Times releases database of California cases

This article was first published in the LA Times

To understand a new disease, start at the beginning

Would you know if you had COVID-19?